AMTB vs RMD · P/E 16, rev $268.7M vs P/E 29, rev $5.65B
Amerant Bancorp Inc. (AMTB) versus ResMed Inc (RMD) — a side-by-side from cached financials, not a winner call.
Amerant Bancorp Inc. (AMTB) is a banks - regional company listed on US.
ResMed Inc (RMD) is a medical instruments & supplies company listed on US.
Latest reported AMTB revenue for 2026-06-30 was $268.7M. Net income was $38.9M. AMTB currently screens at market cap $896.5M and trailing P/E 16.0.
Latest reported RMD revenue for 2026-06-30 was $5.65B. Net income was $1.52B. Revenue was up 9.9% from 2025-06-30 to 2026-06-30. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
AMTB currently screens at market cap $896.5M and trailing P/E 16.0. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
Not investment advice. Open the AMTB and RMD stock pages for the full models.
Not investment advice.